Stocks Health care CNXU
NASDAQ · Health careConexeu Sciences Inc. (CNXU)
At July 31, 2026 it held $2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 14, 2026.
Key facts about Conexeu Sciences Inc.
- Net worth
- Conexeu Sciences Inc. has a market value (market cap) of $62.3M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on September 14, 2026 and covers the period to July 31, 2026. Open on SEC EDGAR
What Conexeu Sciences Inc. does
Conexeu Sciences Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker CNXU.
Earnings: every quarter and the next report date
Latest SEC filings
What Conexeu Sciences Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 27, 2026
- October 20, 2026
- September 15, 2026Activist stake changed SCHEDULE 13D/A
- September 14, 2026
- September 10, 2026
- September 4, 2026Passive stake changed SCHEDULE 13G/A
- September 4, 2026Passive stake (5% or more) SCHEDULE 13G
- August 18, 2026Activist stake (5% or more) SCHEDULE 13D
- August 18, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
Insider trades
What the people running Conexeu Sciences Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $500K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 15, 2026 | Purcell Lynn SebastianDirector, 10% owner | Boughtindirect | 166,666 | $500K |
| September 25, 2026 | Bogart David RobertChief Commercial Officer, Director | Exercised options | 750,000 | $750 |
| September 14, 2026 | Sharpe Jeffrey NathanDirector | Exercised options | 500,000 | $500 |
| September 4, 2026 | Purcell Lynn SebastianDirector, 10% owner | Exercised optionsindirect | 217,608 | $500.5K |
| September 4, 2026 | Purcell Lynn SebastianDirector, 10% owner | Exercised optionsindirect | 217,608 | $500.5K |
| June 18, 2026 | Purcell Lynn SebastianDirector, 10% owner | Boughtindirect | 202,500 | $162K |
| June 18, 2026 | Wright Michael G.10% owner | Exercised optionsindirect | 250,000 | $250 |
| May 26, 2026 | Wright Michael G.10% owner | Exercised optionsindirect | 400,000 | $400 |
Who owns CNXU
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Purcell Lynn Sebastian13G, passive with 1 related filers | 12.3% | August 14, 2026 |
| Wright Michael G.13G, passive | 12.1% | July 28, 2026 |
| Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund13G, passive | 9.99% | September 4, 2026 |
| David Bogart13G, passive | 8.1% | August 18, 2026 |
| OnePointTwo Capital Ventures LLC13G, passive | 6.8% | August 14, 2026 |
| Paisley Capital Holdings Corp13G, passive | 6.7% | July 20, 2026 |
| OnePointTwo Capital Ventures II LLC13G, passive | 5.5% | August 14, 2026 |
| Jeffrey Sharpe13D, may seek influence | 5.2% | September 15, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 8 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| UBS Group AG | 12,264 | new |
| Morgan Stanley | 5,871 | new |
| Citigroup Inc | 5,219 | new |
| Hollencrest Capital Management | 1,000 | new |
| Royal Bank of Canada | 887 | new |
| Integrated Wealth Concepts LLC | 400 | new |
| Jones Financial Companies Lllp | 100 | new |
| Osaic Holdings, Inc. | 100 | new |
Insiders
6 insiders reported holding 10,059,885 shares in total, about $22.3M at the last price.
| Holder | Shares |
|---|---|
| Purcell Lynn SebastianDirector, 10% owner | 3,118,5143,118,514 held indirectly |
| Wright Michael G.10% owner | 2,148,0482,148,048 held indirectly |
| Bogart David RobertChief Commercial Officer, Director | 1,812,500 |
| Sharpe Jeffrey NathanDirector | 1,500,000 |
| OnePointTwo Capital Ventures LLC10% owner | 1,047,500 |
| Lorenc Zbigniew PaulDirector | 433,323 |
Questions about CNXU
What does Conexeu Sciences Inc. do?
Conexeu Sciences Inc. is a company in the Health care sector, listed on NASDAQ as CNXU. Its shares trade on NASDAQ under the ticker CNXU.
What is Conexeu Sciences Inc.'s net worth?
Conexeu Sciences Inc. has a market value (market cap) of $62.3M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
When did Conexeu Sciences Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on September 14, 2026. It covers the period to July 31, 2026. Its newest filing of any kind is the unregistered share sale from October 27, 2026.
Similar companies
Compare CNXU with
Follow CNXU
Get an email when Conexeu Sciences Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Conexeu Sciences Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.